| Tag | Content |
|---|
EnhancerAtlas ID | HS105-53246 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr22:37538550-37539260 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr22:37538953-37538974 | TCTCCCTCCCCATTTTCCCCC | - | 6.13 | | ZNF263 | MA0528.1 | chr22:37539021-37539042 | TCTTCCTCTTCTCCCTGACCC | - | 6 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_18351 | chr22:37537515-37547217 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19129 | chr22:37538027-37547100 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20106 | chr22:37537343-37547292 | CD56 | | SE_22454 | chr22:37537701-37547296 | CD8_primiary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GCCTTTCATG GCAAAAGACC CTCTTTAGAA GAACAGGAAG GACCCACACA GCTGGCCCAA 60
GGGACTCTTC TCAGATCTCT CTGCTGCCAG GATGGCACCA GGCAGCAAGG CCAGGCTGGG 120
GCCCCTGTGC CAACCACTGT GAGGGGCACT GCCTCCCCCA CTGGCTCCAT GGCATTCCTC 180
CCTCATGGGC ACCTTGTCCT GCTCCCTCAT CCCAGCCTGG TCCCACGGCA GCTGGAGTGA 240
TCTAGAAACA CAAACCACTT CAAGACAGGC AGTCCTCCCC ACCTAGAGCC CTCCAAAGCT 300
CCATGAGGCT TAGGATGAAG ATAGATCCTT AATTAGGCCT TCAGAGCCGT GTGGAATCAC 360
CACCCACCCA GAAGCCAGGG CCCGAACCTG CCTTACCCCT CCATCTCCCT CCCCATTTTC 420
CCCCACCCCA CACCCTATGG AATCCACCTG GGCCCAGCCA CCTCTCTGTG GTCTTCCTCT 480
TCTCCCTGAC CCCATCAAGC CTACCTGGGG TCAGTCCCTC ACTCACTGGC CGCCTGGATG 540
TTTACATCAC AGTGACATCT CTCTCCCATC CACCAGGCAC CCAAACCACT CCCAGGTTCC 600
CTGTCCCCAC AGCTGCCTAC AGGGTCTCTC AAAATCCGAG CTTATCCAAA AAGCTTGGGG 660
ACCCTCCTTT CTCCCCACTT CCTCTCTGCT TGCCTCTAGA GTGGAGTCCA 710
|
